Home January 2, 2015 Full March 22, 2004, Issue in PDF January 2, 2015 Reprints Related Articles Which Is the Key Lead? Cefepime and Enmetazobactam Injection (Exblifep) Comparing Early vs. Late-Onset MS Timing of Biomarker Changes in Alzheimer’s Disease Better Outcomes for Acute Stroke Patients Who Arrive Rapidly at Endovascular-Capable Centers